Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY: WST )

223.73 -0.50 (-0.22%)
Official Closing Price Updated: 4:10 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Where West Pharmaceutical Servs Stands With Analysts
Via Benzinga
Why West Pharmaceutical Services Stock Is Heading South Today
The company reported disappointing Q3 results. 
Via The Motley Fool
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Earnings Outlook For West Pharmaceutical Servs
Via Benzinga
Monday Is Your Last Chance To Buy West Pharmaceutical Servs Before The Dividend Payout
Via Benzinga
3 Worst Performing Dividend Aristocrats In 2022
The year 2022 proved difficult to traverse for investors. But the dividend growth investing strategy performed reasonably well, in many cases. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Via Benzinga
West Pharmaceutical Services Shares Slides Post Q1 Results
Via Benzinga
7 Dividend Stocks Set to Surge Higher in 2023
Dividend stocks are as smart a choice as ever given the economy's uncertain outlook. Here are seven top-notch dividend stocks to buy. 
Via InvestorPlace
West Pharmaceutical Servs's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Monday marks the last chance for investors to receive the next dividend payout from West Pharmaceutical Servs (NYSE:WST). 
Via Benzinga
West Pharmaceutical Servs's Return On Capital Employed Overview
According to Benzinga Pro, during Q3, West Pharmaceutical Servs (NYSE:WST) earned $120.60 million, a 36.02% increase from the preceding quarter. West Pharmaceutical Servs's sales decreased to $686.90... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
Upgrades 
Via Benzinga
Pinterest To Surge Over 14%? Plus This Analyst Boosts PT On Apple
  Barclays raised the price target on Apple Inc. (NASDAQ: AAPL) from $155 to $156. Apple shares gained 0.6% to $145.60 in pre-market trading. 
Via Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... 
Via Benzinga
Why West Pharmaceutical Services Shares Hit A New 52-Week Low Thursday
West Pharmaceutical Services Inc. (NYSE: WST) shares are trading lower by 11.94% to $224.02 during Thursday's session after the company reported worse-than-expected Q3 EPS and sales results and lowered... 
Via Benzinga
Credit Suisse, Meta Platforms, Wolfspeed And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded mixed, with the Dow Jones gaining more than 300 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Recap: West Pharmaceutical Q3 Earnings
West Pharmaceutical Servs (NYSE:WST) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million. 
Via Benzinga
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 838 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 456 stocks hit new 52-week lows. 
Via Benzinga
Here's How Much $1000 Invested In West Pharmaceutical Servs 10 Years Ago Would Be Worth Today
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 10 years by 18.96% on an annualized basis producing an average annual return of 30.3%. Currently, West Pharmaceutical... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
West Pharmaceutical Servs's Return On Capital Employed Insights
According to Benzinga Pro, during Q2, West Pharmaceutical Servs (NYSE:WST) earned $188.50 million, a 8.46% increase from the preceding quarter. West Pharmaceutical Servs also posted a total of $771.30... 
Via Benzinga
West Pharmaceutical Services: Q2 Earnings Insights
  West Pharmaceutical Servs (NYSE:WST) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For July 28, 2022
Companies Reporting Before The Bell • ArcelorMittal (NYSE:MT) is estimated to report earnings for its second quarter. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 435 companies set new 52-week lows. 
Via Benzinga
West Pharmaceutical Servs: Q1 Earnings Insights
West Pharmaceutical Servs (NYSE:WST) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.